Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Lumiera Health Inc. (V:NHP)

Business Focus: Pharmaceuticals (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for NHP within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jul 05, 2022 13:50 ET
Lumiera reports first half of 2022 results with a 40% increase compared to previous year
MONTREAL, July 5, 2022 /CNW Telbec/ - Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to provide an update to announce that the corporate strategy and plans that were put place in 2021, are continuing to prove successful with Lumiera's first half of 2022 improving its sales by +40% compared to last year first half results.
Read full article
Jun 09, 2022 09:00 ET
Lumiera Health launches US sales of Awaye pain relief cream with first shipment to Amazon.com
MONTREAL, June 9, 2022 /CNW/ - Lumiera Health Inc.  (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to announce the launch of its Awaye™ pain relief cream in the US market. The first shipment of Awaye™ has been sent to Amazon.com's distribution center and will soon be available to American consumers.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.88
--
--
Price to Sales - TTM
2.39
5.37
4.29
Price to Book - most recent quarter
--
2.08
1.79
Price to Cash Flow per share - TTM
--
5.53
8.07
Price to Free Cash Flow per share - TTM
--
7.03
18.98
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jul 31, 2022996-5,000
Jul 15, 20225,996-2,332
Jun 30, 20228,328-6,391
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Lumiera Health Inc. is a Canada-based natural health product company. The Company is focused on selling natural products as well as the development and commercialization of botanical-based products for human health care. The Company also operates as product development, marketing and sales business of natural products. The Company's products and brands include Holizen, Awaye pain relief cream and Bazzzics. The company is also providing solutions for chronic pain and inflammation. It is also helping people to improve health by delivering products. The Company's subsidiary is Holizen Laboratory Inc.

See business summary

 

Twitter

Search (past week) for $NHP.CA NHP.V

  • No tweets found